ENXTAM:PHIAMedical Equipment
Philips IntraSight Plus Launch Tests Thesis On Integrated Cardiology Workflows
Koninklijke Philips has launched IntraSight Plus, an integrated interventional guidance platform for coronary procedures.
The system combines advanced imaging and physiological assessment tools in a single platform.
IntraSight Plus is cleared for clinical use in the USA and Europe and connects with Philips Azurion and PACS systems.
For investors watching ENXTAM:PHIA, this launch sits against a share price of €23.72 and a mixed recent performance, with the stock up 2.4% over the past week...